Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T19:02:24.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T14:38:44.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, along with specific medical terms related to differentiated thyroid carcinoma and cabozantinib, while removing various related topics and location descriptors.
    Difference
    2%
    Check dated 2025-08-31T11:45:40.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:55:34.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.